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(EtOAc/hexane; 3:7); 1 H NMR (CDCl 3 , 400 MHz) δ 2.02 (s, 3H), 3.78 (s, 3H), 6.32 (d, J = 8. 1 Hz, 2H) , 6.96 (t, J = 8.2 Hz, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 8. 8, 55.5, 101.0, 108.3, 110.3, 126.4, 145.5, 158.1; IR (neat) 3369, 2936, 2835, 1620, 1587, 1471, 1259, 1134, 1097, 766, 707 
3-Methoxy-2-methylbenzenediazonium tetrafluoroborate (18)
Aniline 17 (2.3 g, 16.8 mmol) was added to a 50% aqueous solution of fluoroboric acid (15 mL) at room temperature and stirred for 5 min. The mixture was cooled in an ice bath for 10 min and an aqueous solution of NaNO 2 (1.4 g, 20. 3 mmol in 2.6 mL H 2 O) was added to the mixture. The reaction mixture was stirred at 10°C for 30 min, during which the product precipitated. This increased the viscosity of the solution and the colour changed to pale yellow. The cooled reaction mixture was filtered through a Büchner funnel and the solid product washed with small amounts of H 2 O, MeOH and Et 2 O and dried under high vacuum to obtain 18 (3.6 g, 15. 3 mmol, 91%) as a pale brown solid: 1 H NMR (D 2 O, 400 MHz) δ 1.96 (s, 3H), 3.74 (s, 3H), 6.50 (d, J = 8.2 Hz, 1H), 6.56 (d, J = 8.3 Hz, 1H), 7.02 (t, J = 8.2 Hz, 1H); 13 C NMR (D 2 O, 100 MHz) δ 7.5, 56.0, 103.8, 108.7, 126.7, 126.9, 144.5, 158.2; IR (neat) 3211, 2359 IR (neat) 3211, , 1588 IR (neat) 3211, , 1471 IR (neat) 3211, , 1240 IR (neat) 3211, , 1104 . This compound can be stored at -20°C for a limited period of time but preferably is used as soon as possible in the next step.
4-Methoxy-1H-indazole (8a)
In a dry flask 18-crown-6 (0.18 g, 0.68 mmol) and potassium acetate (2.9 g, 29.4 mmol) were dried under high vacuum for 1 h and anhyd. CHCl 3 (140 mL) was added and stirred at room temperature for 10 min. Then 18 (3.5 g, 14.9 mmol) was added to the mixture in small portions under N 2 atmosphere. The reaction mixture was stirred at room temperature for 3 h. The reaction mixture was filtered and the residue washed with CHCl 3 . The filtrate was washed with water (3 × 40 mL) and the organic layer was dried over Na 2 SO 4 , filtered and concentrated in vacuo to give the crude product. The crude product was purified by flash column chromatography (hexane/EtOAc; 9:1) to afford 8a (1.8 g, 12. 2 mmol, 82%) as a yellow solid: mp 117-120 °C; R f = 0.13 (hexane/EtOAc; 7:3); 1 H NMR (CDCl 3 , 400 MHz) δ 3.98 (s, 3H), 6.49 (d, J = 7.6 Hz, 1H), 7.09 (d, J = 8.3 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 8.19 (s, 1H) , 10.80 (br, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 55. 4, 99.8, 102.5, 115.3, 128.1, 132.7, 142.0, 153.8; IR (neat) 3175, 2956, 2361, 2339, 1593, 1518, 1370, 1254, 1110, 983, 947, 869, 776, 734, 687 cm -1 ; HRMS-ESI (+) m/z calcd for C 8 H 9 N 2 O 149.0715 [M+H] + , found 149.0709 [M+H] + ; Anal. calcd for C 8 H 8 N 2 O: C 64.85%, H 5.44%, N 18.91%, found C 64.74%, H 5.50%, N 18.76%.
4-Methoxy-2-{[(2-trimethylsilyl)ethoxy]methyl}-2H-indazole (19)
To a stirred solution of compound 8a (1.5 g, 10.1 mmol) in anhyd. THF (50 mL) was added N,N-dicyclohexylmethylamine (2.60 g, 13.3 mmol), followed by SEM-chloride (2.02 g, 12.2 mmol) addition and stirring at room temperature. After 12 h, TLC analysis showed presence of starting material. The reaction was continued by adding one more equivalent of N,N-dicyclohexylmethylamine and SEM-chloride and stirring for another 12 h. The THF was removed under reduced pressure and the crude reaction mixture was extracted with EtOAc (3 × 20 mL) and washed with 0.5 M NaOH (10 mL). The combined organic phases were washed with H 2 O (10 mL), dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (hexane/EtOAc; 9:1) to afford 19 (2.3 g, 8.3 mmol, 83%) as a dark brown oil: R f = 0.35 (hexane/EtOAc; 7:3); 1 H NMR (CDCl 3 , 400 MHz) δ 0.00 (s, 9H), 0.97 (t, J = 7.9 Hz, 2H), 3.66 (t, J = 8.0 Hz, 2H), 3.97 (s, 3H), 5.72 (s, 2H), 6.36 (d, J = 7.2 Hz, 1H), 7.24 (t, J = 8.0 Hz, 1H), 7.34 (d, J = 8.7 Hz, 1H), 8.18 (s, 1H) ; 13 C NMR (CDCl 3 , 100 MHz) δ 0.0, 18.0, 56.6, 68.9, 83.3, 100.0, 111.8, 117.7, 122.8, 128.7, 151.9, 155.0; IR (neat) 2929 IR (neat) , 2855 IR (neat) , 2362 IR (neat) , 1561 IR (neat) , 1416 IR (neat) , 1263 IR (neat) , 1139 IR (neat) , 1092 cm -1 ; HRMS-ESI (+) m/z calcd for C 14 H 22 N 2 NaO 2 Si 301.1348 [M+Na] + , found 301.1343
[M+Na] + . The N-2 substitution was confirmed by nOe difference studies.
Ethyl 4-methoxy-2-{[(2-trimethylsilyl)ethoxy]methyl}-2H-indazole-3-carboxylate (20)
Indazole 19 (0.3 g, 1.1 mmol) was dissolved in anhyd. THF (5 mL) and stirred at -78°C for 10 min under N 2 atmosphere. Then 1.6 M solution of n BuLi in hexane (0.74 mL, 1.2 mmol) was added drop wise to the mixture at -78°C and stirred for 30 min. The reaction was briefly warmed to room temperature in 10 min, the colour changed to dark brown. The flask was re-cooled to -78°C and a solution of ethyl cyanoformate (0.13 g, 1.3 mmol) in anhyd. THF (2 mL) was added drop wise and stirred for 2 h. The reaction mixture was then slowly allowed to warm to room temperature. The reaction was stopped by adding saturated solution of NH 4 Cl. The THF was removed under reduced pressure. The aqueous layer was extracted with EtOAc (3 × 10 mL) and the combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (hexane/EtOAc; 8:2) to afford 20 (0.27 g, 0.78 mmol, 72%) as a brown oil: R f = 0.39 (hexane/EtOAc; 7:3); 1 H NMR (CDCl 3 , 400 MHz) δ 0.00 (s, 3H), 0.95 (t, J = 8.3 Hz, 2H), 1.52 (t, J = 7.1 Hz, 3H), 3.62 (t, J = 8.2 Hz, 2H), 3.99 (s, 3H), 4.56 (q, J = 7.1 Hz, 2H), 6.07 (s, 2H), 6.55 (d, J = 7.4 Hz, 1H), 7.31 (t, J = 8. 1 Hz, 1H), 7.40 (d, J = 8.6 Hz, 1H ); 13 C NMR (CDCl 3 , 100 MHz) δ 0.0, 15.7, 19.2, 56.8, 63.2, 68.7, 82.7, 103.2, 112.2, 116.8, 127.2, 129.0, 150.7, 154.8, 162.3; IR (neat) 2951 IR (neat) , 2899 IR (neat) , 1708 IR (neat) , 1557 IR (neat) , 1246 IR (neat) , 1229 IR (neat) , 1107 IR (neat) , 1050 
Ethyl 4-methoxy-1H-indazole-3-carboxylate (9a)
Ester 20 (0.4 g, 1.1 mmol) was dissolved in EtOH (12 mL) and 2 M HCl (10 mL) was added drop wise and stirred at room temperature for 12 h. The reaction was monitored by TLC and neutralized by adding solid Na 2 CO 3 , then filtered and washed with EtOH. The filtrate was concentrated under vacuo to remove EtOH and the aqueous layer was extracted with EtOAc (3 × 15 mL). The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to give 9a (0.24 g, 1. 3, 55.7, 61.3, 102.6, 103.6, 113.4, 129.0, 136.9, 143.5, 153.9, 162.7; IR (neat) 3175, 2978 IR (neat) 3175, , 1690 IR (neat) 3175, , 1507 IR (neat) 3175, , 1294 IR (neat) 3175, , 1254 IR (neat) 3175, , 1159 IR (neat) 3175, , 1050 
Ethyl 4-methoxy-1-methyl-1H-indazole-3-carboxylate (21)
Ester 9a (0.2 g, 0.91 mmol) was dissolved in anhyd. THF (5 mL) and cooled to 0°C, then a solution of KO t Bu (0.12 g, 0.99 mmol) in anhyd. THF (2 mL) was added drop wise and stirred for 15 min. A solution of MeI (0.15 g, 1.1 mmol) in anhyd. THF (2 mL) was added to the mixture and warmed to room temperature and stirred for 5 h. The progress of the reaction was monitored by TLC. The THF was removed in vacuo and the aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (hexane/EtOAc; 8:2) to afford 21 (0.19 g, 0.82 mmol, 90%) as a white solid: mp 88-90°C; R f = 0.10 (hexane/EtOAc; 7:3); 1 3, 36.5, 55.8, 61.3, 102.0, 102.2, 114.2, 128.3, 136.9, 143.2, 154.1, 162.7; IR (neat) 2982 IR (neat) , 2934 IR (neat) , 1707 IR (neat) , 1576 IR (neat) , 1508 IR (neat) , 1458 IR (neat) , 1368 IR (neat) , 1270 IR (neat) , 1234 IR (neat) , 1211 IR (neat) , 1080 IR (neat) , 1026 ; HRMS-ESI (+) m/z calcd for C 12 H 14 N 2 NaO 3 257.0902 [M+Na] + , found 257.0897 [M+Na] + . The N-1 methylation was confirmed by difference nOe studies.
4-Methoxy-1-methyl-1H-indazole-3-carboxylic acid (10a)
Indazole ester 21 (0.1 g, 0.43 mmol) was dissolved in MeOH (8 mL) and 2 M NaOH (2 mL) was added and stirred at room temperature for 8 h. The TLC analysis of the reaction showed disappearance of starting material, the reaction was acidified to pH 2 and extracted with CH 2 Cl 2 (3 × 10 mL). The combined organic phases were washed with water (5 mL), dried over Na 2 SO 4 , filtered and concentrated to afford 10a (0.086 g, 0.42 mmol, 98%) as a white solid: mp 204-207°C; R f = 0.38 (CH 2 Cl 2 /MeOH; 7:3); 1 H NMR (CD 3 OD, 400 MHz) δ 4.16 (s, 3H), 4.17 (s, 3H), 6.74 (d, J = 7.7 Hz, 1H), 7.16 (d, J = 8.5 Hz, 1H), 7.42 (t, J = 8.1 Hz, 1H), 11.57 (br, 1H); 13 C NMR (CD 3 OD, 100 MHz) δ 36. 7, 56.7, 102.4, 104.3, 112.8, 128.2, 143.2, 150.4, 160.4, 169.6; IR (neat) 3156, 3100, 1734 IR (neat) 3156, 3100, , 1509 IR (neat) 3156, 3100, , 1395 IR (neat) 3156, 3100, , 1358 IR (neat) 3156, 3100, , 1264 IR (neat) 3156, 3100, , 1211 IR (neat) 3156, 3100, , 1057 ; HRMS-ESI (+) m/z calcd for C 10 H 10 N 2 NaO 3 229.0589 [M+Na] + , found 229.0584 [M+Na] + .
9-Methyl-9-azabicyclo[3.3.1]nonan-3-one (22)
To a solution of glutaraldehyde (25.0 g, 250 mmol) in H 2 O (170 mL) were added a solution of methylamine hydrochloride (25.0 g, 370 mmol) dissolved in H 2 O (250 mL), acetone-1,3-dicarboxylic acid (42.0 g, 287 mmol) dissolved in H 2 O (410 mL), and Na 2 HPO 4 · 12 H 2 O (44.0 g, 123 mmol) and NaOH (3.6 g, 90 mmol) dissolved in H 2 O (100 mL) at room temperature. Carbon dioxide was evolved, and the mixture was stirred for 24 h at room temperature. Then concentrated HCl (16 mL) was added and the solution was heated on a steam bath for 1 h to complete the decarboxylation. After the solution has been cooled to room temperature, NaOH (38.0 g, 950 mmol) in H 2 O (50 mL) was added and the basic mixture was extracted with CH 2 Cl 2 (4 × 150 mL). The combined organic layers were dried over Na 2 SO 4 and concentrated to half volume and filtered through a layer of alumina, then eluted with CH 2 Cl 2 . The eluate was concentrated under reduced pressure to yield 22 (27.0 g, 176 mmol, 71%) as a pale yellow solid: mp 63-67°C; R f = 0.34 (CH 2 Cl 2 /MeOH; 8:2); 1 H NMR (CDCl 3 , 400 MHz) δ 1.30-1.52 (m, 4H), 1.83-1.95 (m, 2H), 2.23 (d, J = 16.6 Hz, 2H), 2.56 (s, 3H), 2.70 (dd, J = 6.7 Hz, J = 16.6 Hz, 2H), 3.22-3.27 (m, 2H); 13 C NMR (CDCl 3 , 100 MHz) δ 15.9, 29.5, 41.1, 41.7, 55.6, 210.6; IR (neat) 2931 IR (neat) , 2917 IR (neat) , 2902 IR (neat) , 1696 IR (neat) , 1269 IR (neat) , 1187 IR (neat) , 1101 IR (neat) , 1016 
9-Methyl-9-azabicyclo[3.3.1]nonan-3-one oxime (23)
Sodium acetate (7.5 g, 91.4 mmol) and hydroxylamine hydrochloride (8.75 g, 125 mmol) were pulverized in a mortar to a thin paste and extracted with methanol, the salt was filtered off and the solution was treated with 22 (5.0 g, 32.6 mmol) and stirred for 4 h at room temperature. The reaction mixture was concentrated under reduced pressure and the residue was treated with aqueous K 2 CO 3 and extracted with CHCl 3 (5 × 50 mL) containing 5% i PrOH. The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to yield 23 (5.3 g, 31.4 mmol, 96%) as a pale yellow solid: mp 126-127°C; R f = 0.15 (CH 2 Cl 2 /MeOH; 8:2); 1 Hz, 1H), 3.08-3.09 (m, 2H), 9.10 (br, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 16. 6, 24.8, 28.8, 29.5, 30.9, 40.9, 53.0, 53.8, 158.8; IR (neat) 3055, 2939 IR (neat) 3055, , 2909 IR (neat) 3055, , 1099 
(3-endo)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine (11)
A solution of concentrated H 2 SO 4 (0.75 mL) in anhyd. THF (2 mL) was added to a cooled and stirred mixture of LiAlH 4 (0.95 g, 25 mmol) in anhyd. THF (15 mL) at -10°C under N 2 atmosphere. The mixture was allowed to stand overnight at room temperature. A solution of 23 (1.0 g, 5.9 mmol) in anhyd. THF (10 mL) was added drop wise to the stirred mixture at 30°C and allowed to react further at 40°C for 3 h. The reaction mixture was cooled to 10°C and a solution of H 2 O (0.82 mL) in THF (2 mL) was added and stirred at 30°C for 1 h. The resulting precipitate was filtered off and the residue was washed several times with CH 2 Cl 2 and Et 2 O. The combined organic layers were washed with sat. NaHCO 3 (10 mL) and dried over Na 2 SO 4 , filtered and concentrated to give 11 as colourless oil (0.72g, 4.7 mmol, 80%) which solidified to a waxy solid on standing: R f = 0.05 (CH 2 Cl 2 /MeOH; 8:2); 1 H NMR (CDCl 3 , 400 MHz) δ 0.84-0.95 (m, 2H), 0.99-1.06 (m, 2H), 1.36-1.41 (m, 1H), 1.85-1.88 (m, 3H), 2.18-2.26 (m, 2H), 2.38 (s, 3H), 2.93 (d, J = 10.7 Hz, 2H), 3.15 (tt, J = 6.4 Hz, J = 11.4 Hz, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 14.0, 24. 1, 37.0, 40.1, 42.2, 51.3; IR (neat) 3281, 2928 IR (neat) 3281, , 2855 IR (neat) 3281, , 1437 IR (neat) 3281, , 1370 IR (neat) 3281, , 1025 
4-Methoxy-1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide (2b)
Indazole acid 10a (0.08 g, 0.39 mmol), DCC (0.10 g, 0.50 mmol) and HOBt (0.052 g, 0.39 mmol) were mixed together in a flask and dried under high vacuum for 1 h before dissolving in dry DMF:CH 2 Cl 2 (1:4, 10 mL), and then stirring the mixture for 2 h at room temperature. A solution of amine 11 (0.066 g, 0.43 mmol) in dry CH 2 Cl 2 (2 mL) was added drop wise to the mixture under N 2 atmosphere and stirred for 24 h at room temperature. The progress of the reaction was monitored by TLC. The solvents were removed in vacuo and the crude product was extracted with CH 2 Cl 2 (3 × 20 mL) and washed with sat. NaHCO 3 (10 mL). The combined organic phases were dried over Na 2 SO 4 , filtered 25.8, 33.5, 36.4, 40.7, 42.1, 52.7, 56.4, 103.1, 104.5, 113.2, 129.5, 138.6, 144.7, 153.7, 163.4; IR (neat) 3340, 2924 IR (neat) 3340, , 1635 IR (neat) 3340, , 1612 IR (neat) 3340, , 1541 IR (neat) 3340, , 1264 IR (neat) 3340, , 1025 
4-Hydroxy-1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide (2a)
To a solution of compound 2b (0.07 g, 0.20 mmol) in dry DMF (8 mL) was added NaSEt (0.086 g, 1.0 mmol) and heated at 110 °C for 18 h. The progress of the reaction was monitored by TLC. The reaction was cooled and stopped by adding aqueous solution of NH 4 Cl. The aqueous layer was extracted several times with CH 2 Cl 2 , until the aqueous layer was free from the product. The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (CH 2 Cl 2 then CH 2 Cl 2 /MeOH/Et 3 N; 96:3:1) to afford 2a (0.062 g, 0.19 mmol, 93%) as a white solid: mp 104-108°C; R f = 0.23 (CH 2 Cl 2 /MeOH; 7:3); 1 9, 25.4, 33.0, 36.5, 40.4, 42.2, 52.8, 100.9, 106.7, 115.2, 130.4, 137.9, 144.8, 152.7, 164.7; IR (neat) 2916 IR (neat) , 2858 IR (neat) , 1583 IR (neat) , 1555 IR (neat) , 1268 IR (neat) , 1050 
1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-4-(phenylmethoxy)-1Hindazole-3-carboxamide (2c)
Compound 2a (0.020 g, 0.061 mmol) was dissolved in dry acetone (2 mL) and solid Na 2 CO 3 (0.017 g, 0.12 mmol) was added which was followed by drop wise addition of benzyl bromide (0.011 g, 0.067 mmol) and stirring at room temperature. The reaction was monitored by TLC and found complete in 5 h. The acetone was concentrated under reduced pressure and the residue was extracted with CH 2 Cl 2 (3 × 10 mL). The combined organic layers were dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (CH 2 Cl 2 then CH 2 Cl 2 /MeOH/Et 3 N; 96:3:1) to afford 2c ( 13.8, 25.0, 31.9, 36.4, 39.6, 41.2, 54.0, 72.3, 104.6, 115.2, 129.6, 129.8, 129.9, 130.0, 130.1, 137.9, 144.8, 152.7, 164.7; IR (neat) 2955 IR (neat) , 2361 IR (neat) , 1541 IR (neat) , 1257 IR (neat) , 1231 IR (neat) , 1054 IR (neat) , 1033 IR (neat) , 1024 
4-Methoxy-2-methylbenzenediazonium tetrafluoroborate (24)
Following the procedure for 18, 4-methoxy-2-methylbenzeneamine (1.0 g, 7.3 mmol), 50% aq. fluoroboric acid (6.5 mL) and NaNO 2 (0.56 g, 8.1 mmol) gave 24 as a magenta-coloured solid ( 5, 56.8, 109.1, 109.2, 123.1, 142.1, 162.7, 163.9 ; IR (neat) ) 2244, 1529, 1489, 1268, 1012, 823, 714 cm -1 . This compound can be stored at -20°C for a limited period of time but is preferably used as soon as possible in the next step.
5-Methoxy-1H-indazole (8b)
Following the procedure for 8a, 18-crown-6 (0.06 g, 0.23 mmol), potassium acetate (0.909 g, 9.3 mmol) and 24 (1.0 g, 4.2 mmol) afforded a crude product which was purified by flash chromatography (hexane/EtOAc; 3:1) to yield 8b (0.52 g, 3.5 mmol, 83%) as a shiny yellow solid: mp 97-99°C; R f = 0.31 (hexane/EtOAc; 3:1); 1 H NMR (CDCl 3 , 400 MHz) δ 3.85 (s, 3H), 7.06 (d, J = 7.5 Hz, 2H), 7.33 (d, J = 7.7 Hz, 1H), 7.95 (s, 1H), 10.89 (br, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 56.5, 108. 9, 112.9, 121.7, 122.8, 131.2, 134.2, 146.3; IR (neat) 3133, 2902 IR (neat) 3133, , 1602 IR (neat) 3133, , 1513 IR (neat) 3133, , 1265 IR (neat) 3133, , 1156 
5-Methoxy-2-{[(2-trimethylsilyl)ethoxy]methyl}-2H-indazole (25)
Using the procedure for 19, 8b (1.0 g, 6.7 mmol), N,Ndicyclohexylmethylamine ( 18.8, 55.6, 67.9, 80.2, 108.0, 111.2, 120.2, 123.5, 126.7, 137.3, 152.6; IR (neat) 2943 IR (neat) , 1534 IR (neat) , 1265 IR (neat) , 1101 ; HRMS-ESI (+) m/z calcd for C 14 H 22 N 2 NaO 2 Si 301.1348 [M+Na] + , found 301.1348 [M+Na] + . The N-2 substitution was confirmed by nOe differences studies.
Ethyl 5-methoxy-2-{[(2-trimethylsilyl)ethoxy]methyl}-2H-indazole-3-carboxylate (26)
Using the procedure for 20, indazole 25 (0.7 g, 2.5 mmol), 2.5 M solution of n BuLi in hexane (1.1 mL, 2.8 mmol) and ethyl cyanoformate (0.4 g, 4.0 mmol) afforded the crude product which was purified by flash chromatography (hexane/EtOAc; 5:1) to give 26 (0.66 g, 1.9 mmol, 75%) as a yellow oil: R f = 0.35 (hexane/EtOAc; 5:1); 1 9, 16.1, 18.7, 56.8, 62.5, 68.6, 78.1, 102.2, 109.7, 121.6, 124.6, 137.1, 143.0, 151.9, 160.4; IR (neat) 2947 IR (neat) , 2895 IR (neat) , 1714 IR (neat) , 1536 IR (neat) , 1304 IR (neat) , 1263 IR (neat) , 1103 IR (neat) , 1099 
Ethyl 5-methoxy-1H-indazole-3-carboxylate (9b)
Following the procedure for 9a, ester 26 (0.5 g, 1.4 mmol) gave 9b (0.25 g, 1.1 mmol, 79%) as a pale yellow solid: mp 91-96°C; R f = 0.42 (hexane/EtOAc; 3:1); 1 15.2, 57.0, 63.5, 107.9, 114.9, 125.2, 126.3, 132.2, 136.4, 146.2, 163.5; IR (neat) 3146, 2981 IR (neat) 3146, , 1676 IR (neat) 3146, , 1593 IR (neat) 3146, , 1267 IR (neat) 3146, , 1303 IR (neat) 3146, , 1110 IR (neat) 3146, , 1051 ; HRMS-ESI (+) m/z calcd for C 11 H 12 N 2 NaO 3 243.0746 [M+Na] + , found 243.0744 [M+Na] + .
Ethyl 5-methoxy-1-methyl-1H-indazole-3-carboxylate (27)
Following the procedure for 21, ester 9b (0.3 g, 1.4 mmol), KO t Bu (0.18 g, 1.6 mmol) and MeI (0.25 g, 1.8 mmol) afforded the crude product which was purified by flash chromatography (EtOAc/hexane; 1:6) to yield 27 (0.25 g, 1.1 mmol, 77%) as a white solid: mp 122-124°C; R f = 0.21 (hexane/EtOAc; 3:1); 1 1, 111.0, 122.5, 124.6, 131.5, 133.1, 147.2, 160.9; IR (neat) 2990 IR (neat) , 1732 IR (neat) , 1471 IR (neat) , 1265 IR (neat) , 1114 IR (neat) , 1023 , 733 cm -1 ; HRMS-ESI (+) m/z calcd for C 12 H 14 N 2 NaO 3 257.0902 [M+Na] + , found 257.0898 [M+Na] + ; Anal. calcd for C 12 H 14 N 2 O 3 : C 61.53%, H 6.02%, N 11.96%, found C 61.38%, H 6.01%, N 11.97%. The N-1 methylation was confirmed by difference nOe studies.
5-Methoxy-1-methyl-1H-indazole-3-carboxylic acid (10b)
Following the procedure for 10a, ester 27 (0.2 g, 0.85 mmol) afforded 10b (0.17 g, 0.82 mmol, 97%) as a white solid: mp 219-221°C; R f = 0.25 (CH 2 Cl 2 /MeOH; 5:2); 1 H NMR (CDCl 3 , 400 MHz) δ 3.95 (s, 3H), 4.30 (s, 3H), 7.23 (d, J = 5.3 Hz, 1H), 7.78 (d, J = 7.9 Hz, 1H), 8.05 (d, J = 7.9 Hz, 1H) 9.98 (s, 1H).; 13 C NMR (CDCl 3 , 100 MHz) δ 39.0, 52.0, 105. 7, 112.0, 124.6, 125.8, 133.4, 137.7, 148.2, 162.6; IR (neat) 2913 IR (neat) , 1656 IR (neat) , 1499 IR (neat) , 1262 IR (neat) , 1189 IR (neat) , 1116 IR (neat) , 1034 , 734 cm -1 ; HRMS-ESI (-) m/z calcd for C 10 H 9 N 2 O 3 205.0613 [M-H] -, found 205.0614 [M-H] -. Anal. calcd for C 10 H 10 N 2 O 3 : C 58.23%, H 4.89%, N 13.59%, found C58.23%, H 4.87%, N 13.51%.
5-Methoxy-1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide (3b)
Using the procedure for 2b, indazole acid 10b (0.1 g, 0.48 mmol), DCC (0.13 g, 0.63 mmol), HOBt (0.065 g, 0.48 mmol) and amine 11 (0.09 g, 0.58 mmol) yielded the crude product which was purified by flash chromatography (CH 2 Cl 2 then CH 2 Cl 2 /MeOH/Et 3 N; 95:5:1) to give 3b (0.139 g, 0.41 mmol, 85%) as a white solid: mp 186-190°C; R f = 0.18 (CH 2 Cl 2 /MeOH; 9:3); 1 7, 135.5, 146.0, 155.1, 163.4; IR (neat) 3319, 2940 IR (neat) 3319, , 2898 IR (neat) 3319, , 1652 IR (neat) 3319, , 1562 IR (neat) 3319, , 1271 IR (neat) 3319, , 1057 Hydroxy-1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1 
5-

]non-3-yl]-1H-indazole-3carboxamide (3a)
To a solution of compound 3b (100 mg, 0.29 mmol) in dry CH 2 Cl 2 (15 mL) was added a 1 M solution of BBr 3 in CH 2 Cl 2 (3 mL, 3 mmol). The resulting mixture was stirred at room temperature for 24 h. The reaction was stopped with the addition of MeOH and the solvents were evaporated. H 2 O (10 mL) was added and the pH adjusted to 7.5. The aqueous solution was extracted with CH 2 Cl 2 (3 × 5 mL) and the combined organic layers were dried over Na 2 SO 4 , filtered and evaporated to yield 3a (81.0 mg, 0.24 mmol, 84%) as a yellow solid: mp 226-231°C; R f = 0.22 (CH 2 Cl 2 /MeOH; 9:2); 1 3, 25.9, 32.4, 35.3, 42.4, 55.1, 102.4, 106.4, 118.8, 129.5, 135.8, 145.8, 155.2, 164.3; IR (neat) 2940 IR (neat) , 2837 IR (neat) , 1582 IR (neat) , 1570 IR (neat) , 1262 IR (neat) , 1034 Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1 
1-
]non-3-yl]-5-(phenylmethoxy)-1Hindazole-3-carboxamide (3c)
Following the procedure for 2c, compound 3a (0.05 g, 0.15 mmol), solid Na 2 CO 3 (0.031 g, 0.29 mmol) and benzyl bromide (0.03 g, 0.18 mmol) afforded the crude product which was purified by flash chromatography (CH 2 Cl 2 then CH 2 Cl 2 /MeOH/Et 3 N; 95:5:0.5) to give 3c (0.061 g, 0.15 mmol, 96%) as a white solid: mp 137-140°C; 1 15.0, 25.8, 32.6, 35.4, 42.8, 55.6, 72.1, 102.9, 106.1, 119.1, 129.1, 129.2, 135.3, 145.7, 155.2, 164.3; IR (neat) 3410, 2946 IR (neat) 3410, , 2851 IR (neat) 3410, , 1653 IR (neat) 3410, , 1503 IR (neat) 3410, , 1364 IR (neat) 3410, , 1134 IR (neat) 3410, , 1034 
6-Hydroxy-1H-indazole (28)
6-Amino-1H-indazole (1.0 g, 7.5 mmol) was dissolved in 50% H 2 SO 4 (6 ml) and stirred at 0°C for a few minutes. An aqueous solution of NaNO 2 (0.62 g, 9.0 mmol in 2.5 mL H 2 O) was added drop wise via syringe. This was followed by the addition of conc. H 2 SO 4 (1.7 mL) and boric acid (0.6 g, 9.7 mmol) at 0°C and the mixture was stirred for 15 min. The reaction mixture was heated to reflux (130°C) then cooled to room temperature while stirring. A 28% aqueous NH 4 OH solution (2 mL) was added drop wise to the open flask. The mixture was filtered, transferred into a clean flask and more ammonia solution (7.7 mL) was added drop wise until the pH reached 8-9. The weakly alkaline mixture was filtered and the precipitate was washed with H 2 O (1-5 mL) to yield 28 (0.76 g, 5.7 mmol, 76 %) as a yellow solid: mp 126-130°; R f = 0.31 (CH 2 Cl 2 /MeOH; 4:1); 1 H NMR (CDCl 3 , 400 MHz) δ 7.06 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 4.6 Hz, 1H), 7.95 (s, 1H), 9.51 (br s, 1H) ; 13 C NMR (CDCl 3 , 100 MHz) δ 108. 1, 122.5, 123.3, 124.7, 125.0, 126.0, 154.3; IR (neat) 3121, 2905 IR (neat) 3121, , 1590 IR (neat) 3121, , 1302 IR (neat) 3121, , 1146 ; Anal. calcd for C 7 H 6 N 2 O: C 62.68%, H 4.51%, N 20.88%, found C 62.66%, H 4.52%, N 20.87%.
6-Methoxy-1H-indazole (8c)
Indazole 28 (0.5 g, 3.7 mmol) was dissolved in dry acetone (10 mL), solid Na 2 CO 3 (0.78 g, 7.4 mmol) was added and the mixture stirred for 5 min at room temperature. MeI (0.62 g, 4.3 mmol) in dry acetone (1 mL) was added drop wise and stirred at room temperature for 6 h. The acetone was removed in vacuo and the residue was extracted with CH 2 Cl 2 (3 × 10 mL). The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash chromatography (hexane/EtOAc; 4:1) to afford 8c (0.43 g, 2.9 mmol, 78%) as a white solid: mp 97-99°C; R f = 0.31 (hexane/EtOAc; 3:1); 1 2, 109.7, 120.2, 121.7, 122.8, 130.7, 133.5, 146.2; IR (neat) 3108, 2941 IR (neat) 3108, , 1637 IR (neat) 3108, , 1569 IR (neat) 3108, , 1263 IR (neat) 3108, , 1089 
6-Methoxy-2-{[(2-trimethylsilyl)ethoxy]methyl}-2H-indazole (29)
Following the procedure for 19, 8c (1.0 g, 6.7 mmol), N,Ndicyclohexylmethylamine (1.58 g, 8.1 mmol) and SEM-chloride (1.39 g, 8.3 mmol) yielded 29 (1.65 g, 5.9 mmol, 88%) as a yellow oil: R f = 0.32 (hexane/EtOAc; 5:1); 1 H NMR (CDCl 3 , 400 MHz) δ -0.02 (s, 9H), 1.02-1.09 (m, 2H), 3.44-3.52 (m, 2H), 3.97 (s, 3H), 5.33 (s, 2H), 7.25 (d, J = 7.7 Hz, 2H), 7.76 (s, 1H), 8.00 (s, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 0.0, 17. 6, 55.8, 68.2, 81.5, 110.0, 113.2, 120.6, 123.8, 125.2, 137.1, 153.1; IR (neat) 2909 IR (neat) , 1536 IR (neat) , 1264 IR (neat) , 1155 ; HRMS-ESI (+) m/z calcd for C 14 H 22 N 2 NaO 2 Si 301.1348 [M+Na] + , found 301.1352 [M+Na] + . The N-2 substitution was confirmed by nOe differences studies.
Ethyl 6-methoxy-2-{[(2-trimethylsilyl)ethoxy]methyl}-2H-indazole-3-carboxylate (30)
Using the procedure for 20, indazole 29 (0.7 g, 2.5 mmol), 2.5 M solution of n BuLi in hexane (1.1 mL, 2.8 mmol) and ethyl cyanoformate (0.4 g, 4.0 mmol) afforded the crude product which was purified by flash chromatography (hexane/EtOAc; 5:1) to yield 30 (0.63 g, 1.8 mmol, 72%) as a yellow oil: R f = 0.33 (hexane/EtOAc; 5:1); 1 H NMR (CDCl 3 , 400 MHz) δ 0.03 (s, 9H), 1.03-1.10 (m, 2H), 2.08 (t, J = 7.2 Hz, 3H), 4. 13-4.22 (m, 2H) , 4.06 (s, 3H), 5.10 (q, J = 7.1 Hz, 2H), 6.52 (s, 2H), 6.81 (d, J = 7.5 Hz, 1H), 7.24 (d, J = 7.0 Hz, 1H), 7.77 (s, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 0. 9, 16.8, 18.8, 55.5, 65.8, 69.7, 78.2, 108.2, 119.7, 121.5, 124.8, 134.8, 143.5, 150.7, 162.3; IR (neat) 2989 IR (neat) , 2858 IR (neat) , 1767 IR (neat) , 1499 IR (neat) , 1312 IR (neat) , 1278 IR (neat) , 1133 IR (neat) , 1110 
Ethyl 6-methoxy-1H-indazole-3-carboxylate (9c)
Following the procedure for 9a, ester 30 (0.5 g, 1.4 mmol) gave 9c (0.24 g, 1.1 mmol, 76%) as a pale yellow solid: mp 90-94°C; R f = 0.41 (hexane/EtOAc; 3:1); 1 H NMR (CDCl 3 , 400 MHz) δ 2.26 (t, J = 7.1 Hz, 3H), 4.04 (s, 3H), 5.15 (q, J = 7.1 Hz, 2H), 6.95 (d, J = 7.2 Hz, 1H), 7.20 (d, J = 7.0 Hz, 1H), 7.89 (s, 1H), 10.97 (br, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 15.8, 58.0, 63.6, 110.0, 120.0, 123.8, 126.2, 132.7, 135.8, 146.2, 163.8; IR (neat) 3154, 2990 IR (neat) 3154, , 1617 IR (neat) 3154, , 1546 IR (neat) 3154, , 1323 IR (neat) 3154, , 1289 IR (neat) 3154, , 1145 IR (neat) 3154, , 1052 ; HRMS-ESI (+) m/z calcd for C 11 H 12 N 2 NaO 3 243.0746 [M+Na] + , found 243.0741 [M+Na] + .
Ethyl 6-methoxy-1-methyl-1H-indazole-3-carboxylate (31)
Following the procedure for 21, ester 9c (0.3 g, 1.4 mmol), KO t Bu (0.18 g, 1.6 mmol) and MeI (0.25 g, 1.8 mmol) gave a crude product which was purified by flash chromatography (hexane/EtOAc; 6:1) to yield 31 (0.25 g, 1.1 mmol, 78%) as a white solid: mp 121-124°C; R f = 0.23 (hexane/EtOAc; 3:1); 1 1, 58.3, 67.7, 110.0, 111.6, 123.9, 124.9, 131.7, 134.3, 148.2, 161.4; IR (neat) 2890 IR (neat) , 1767 IR (neat) , 1473 IR (neat) , 1287 IR (neat) , 1125 IR (neat) , 1057 ; HRMS-ESI (+) m/z calcd for C 12 H 14 N 2 NaO 3 257.0902 [M+Na] + , found 257.0893 [M+Na] + ; Anal. calcd for C 12 H 14 N 2 O 3 : C 61.53%, H 6.02%, N 11.96%, found C 61.46%, H 6.04%, N 11.96%. The N-1 methylation was confirmed by difference nOe studies.
6-Methoxy-1-methyl-1H-indazole-3-carboxylic acid (10c)
Following the procedure for 10a, ester 31 (0.20 g, 0.85 mmol) afforded 10c (0.17 g, 0.82 mmol, 97%) as a white solid: mp 219-222°C; R f = 0.27 (CH 2 Cl 2 /MeOH; 9:2); 1 H NMR (CDCl 3 , 400 MHz) δ 3.95 (s, 3H), 4.30 (s, 3H), 6.90 (d, J = 7.3 Hz, 1H), 7.78 (d, J = 7.1 Hz, 1H), 8.05 (d, J = 7.7 Hz, 1H) , 10.06 (s, 1H); 13 C NMR (CDCl 3 , 100 MHz) δ 38. 7, 52.1, 109.5, 118.5, 124.5, 125.6, 133.0, 136.1, 149.3, 162.6; IR (neat) 2924 IR (neat) , 1623 IR (neat) , 1404 IR (neat) , 1265 IR (neat) , 1165 IR (neat) , 1135 IR (neat) , 1098 
6-Methoxy-1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide (4b)
Using the procedure for 2b, indazole acid 10c (0.1 g, 0.48 mmol), DCC (0.13 g, 0.63 mmol), HOBt (0.065 g, 0.48 mmol) and amine 11 (0.09 g, 0.58 mmol) afforded the crude product which was purified by flash chromatography (CH 2 Cl 2 then CH 2 Cl 2 /MeOH/Et 3 N; 95:5:1) to yield 4b (0.14 g, 0.41 mmol, 85%) as a white solid: mp 184-188°C; 1 .6, 26.4, 33.1, 36.4, 43.9, 48.8, 55.5, 101.6, 107.8, 117.9, 130.5, 135.9, 145.2, 152.2, 164.5; IR (neat) 2905 IR (neat) , 2831 IR (neat) , 1678 IR (neat) , 1562 IR (neat) , 1255 IR (neat) , 1103 Hydroxy-1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3- 15.0, 26.1, 32.4, 36.1, 43.8, 55.2, 101.5, 107.2, 117.4, 130.4, 136.7, 145.0, 152.5, 164.3; IR (neat) 2951 IR (neat) , 2854 IR (neat) , 1578 IR (neat) , 1564 IR (neat) , 1254 IR (neat) , 1011 
6-
1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-6-(phenylmethoxy)-1Hindazole-3-carboxamide (4c)
Following the procedure for 2c, compound 4a (0.05 g, 0.15 mmol), solid Na 2 CO 3 (0.031 g, 0.29 mmol) and benzyl bromide (0.03 g, 0.18 mmol) gave the crude product which was purified by flash chromatography (CH 2 Cl 2 then CH 2 Cl 2 /MeOH/Et 3 N; 95:5:0.5) to give 4c (0.06 g, 0.14 mmol, 94%) as a white solid: mp 137-140°C; 1 H NMR (CDCl 3 , 400 MHz) δ 1.01-1.09 (m, 2H), 1.10-1.16 (m, 2H), 3H), 3H), 2H), 2.50 (s, 3H), 3.06 (d, J = 10.8 Hz, 2H), 4.02 (s, 3H), 1H), 5.21 (s, 2H), 7.18 (d, J = 8.1 Hz, 1H), 3H), 7.52 (d, J = 7.5 Hz, 2H), 7.63 (d, J = 8.3 Hz, 1H), 7.94 (s, 1H) ; 13 C NMR (CDCl 3 , 100 MHz) δ 15.1, 25.4, 32.4, 35.7, 42.8, 55.8, 72.4, 102.9, 106.2, 119.1, 128.7, 129.9, 135.7, 145.7, 155.1, 163.2; IR (neat) 3412, 2960 IR (neat) 3412, , 2889 IR (neat) 3412, , 1693 IR (neat) 3412, , 1523 IR (neat) 3412, , 1369 IR (neat) 3412, , 1167 IR (neat) 3412, , 1056 
2-Methoxy-6-methylbenzenediazonium tetrafluoroborate (32)
Following the procedure for 18, 2-methoxy-6-methylbenzeneamine (4.0 g, 29.2 mmol), 50% aq. fluoroboric acid (26.0 mL) and NaNO 2 (2.24 g, 32.5 mmol) gave 32 as a pale brown solid (5. 4, 58.4, 111.6, 124.2, 144.0, 144.5, 163.8; IR (neat) 2254 IR (neat) , 1578 IR (neat) , 1492 IR (neat) , 1296 IR (neat) , 1028 . This compound can be stored S12 4, 55.5, 61.0, 105.4, 113.7, 124.0, 124.3, 133.3, 137.0, 145.3, 162.7; IR (neat) 3153, 2985 IR (neat) 3153, , 1701 IR (neat) 3153, , 1585 IR (neat) 3153, , 1265 IR (neat) 3153, , 1242 IR (neat) 3153, , 1125 5, 40.2, 55.6, 60.9, 105.6, 114.0, 123.9, 126.1, 132.6, 137.0, 146.5, 162.7; IR (neat) 2981 IR (neat) , 1699 IR (neat) , 1481 IR (neat) , 1253 IR (neat) , 1133 IR (neat) , 1045 ; HRMS-ESI (+) m/z calcd for C 12 H 14 N 2 NaO 3 257.0902 [M+Na] + , found 257.0891 [M+Na] + ; Anal. calcd for C 12 H 14 N 2 O 3 : C 61.53%, H 6.02%, N 11.96%, found C 61.39%, H 6.01%, N 11.96%.
7-Methoxy-1-methyl-1H-indazole-3-carboxylic acid (10d)
Following the procedure for 10a, ester 35 (0.14 g, 0.6 mmol) afforded 10d (0.12 g, 0.59 mmol, 99%) as a white solid: mp 218-220°C; R f = 0.66 (CH 2 Cl 2 /MeOH; 7:3); 1 H NMR (CD 3 OD, 400 MHz) δ 4.00 (s, 3H), 4.34 (s, 3H), 6.88 (d, J = 7.7 Hz, 1H), 7.18 (t, J = 7.9 Hz, 1H), 7.67 (d, J = 8.2 Hz, 1H); 13 C NMR (CD 3 OD, 100 MHz) δ 40.5, 53. 1, 106.9, 114.9, 125.5, 126.3, 134.1, 138.0, 147.9, 164.3; IR (neat) 2942 IR (neat) , 1670 IR (neat) , 1489 IR (neat) , 1255 IR (neat) , 1148 IR (neat) , 1111 IR (neat) , 1013 -1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1 
7-Methoxy
]non-3-yl]-1H-indazole-3carboxamide (5b)
Using the procedure for 2b, indazole acid 10d (0.1 g, 0.48 mmol), DCC (0.13 g, 0.63 mmol), HOBt (0.065 g, 0.48 mmol) and amine 11 (0.074 g, 0.48 mmol) yielded 5b (0.156 g, 0.46 mmol, 94%) as a white solid: mp 184-188°C (dec.); R f = 0.23 (CH 2 Cl 2 /MeOH; 7:3); 1 H NMR (CD 3 OD, 400 MHz) δ 1.63-1.70 (m, 3H), 1.94-2.01 (m, 2H), 2.16-2.28 (m, 3H), 2.58-2.66 (m, 2H), 2.97 (s, 3H), 3.73 (d, J = 9.9 Hz, 2H), 3.98 (s, 3H), 4.32 (s, 3H), 4.54 (tt, J = 6.7 Hz, J = 11.6 Hz, 1H), 6.85 (d, J = 7.6 Hz, 1H), 7.15 (t, J = 7.9 Hz, 1H), 7.72 (d, J = 8.2 Hz, 1H); 13 C NMR (CD 3 OD, 100 MHz) δ 15.0, 25. 7, 33.3, 40.1, 40.7, 41.5, 52.8, 56.2, 106.9, 115.0, 124.7, 126.3, 134.1, 137.2, 147.9, 164.3; IR (neat) 3315, 2926 IR (neat) 3315, , 2902 IR (neat) 3315, , 1637 IR (neat) 3315, , 1542 IR (neat) 3315, , 1252 
Purity of tested compounds
The purity of the tested compounds was assessed by reversed-phase HPLC (ZORBAX Eclipse XDB-C18, 5 µm, 4.6 × 150 mm) using a MeOH/H 2 O solvent system (Table) . Compounds were eluted with a gradient of 35% MeOH/H 2 O to 100% MeOH with 1% NH 4 OH for 55 min at a flow rate of 1 mL/min. Purity was determined by total absorbance at 254 nm. 
Biological assay
Materials and cell culture maintenance All cell culture reagents were obtained from Gibco BRL (Paisley, UK), except foetal calf serum which was from Labtech International (Ringmer, UK). [ 3 H]granisetron (63.5 Ci/mmol) was from PerkinElmer (Boston, Massachusetts, USA). Human embryonic kidney (HEK)-293 cells were maintained on 90 mm tissue culture plates at 37°C and 7% CO 2 in a humidified atmosphere. Cells were cultured in DMEM:F12 (Dulbecco's modified Eagle medium/nutrient mix F12 (1:1)) with GlutaMAX™ I containing 10% foetal calf serum and passaged when 90% confluent.
Receptor expression and radioligand binding
HEK-293 cells stably expressing the human 5-HT3A subunit (accession number: P46098) were scraped into 1 mL of ice-cold HEPES buffer (10 mM, pH 7.4) and frozen at -20°C. After thawing, they were spun at 13,000 rpm for 1 min, resuspended and 50 µg of cell membranes incubated in 0.5 mL HEPES buffer containing 1 nM [ 3 H]granisetron (~K d ), in the presence or absence of synthetic granisetron derivatives 2-7 (at 10-fold dilutions). Competition binding (12 points) was performed on at least three separate plates of cells. Nonspecific binding was determined using 10 µM quipazine or other competitive antagonist. Reactions were incubated for at least 1 h at 4°C and terminated by vacuum filtration, using a Brandel cell harvester, onto GF/B filters presoaked in 0.3% polyethyleneimine. Radioactivity was determined by scintillation counting using a Beckman LS6000SC (Fullerton, CA, USA). where K i is the equilibrium dissociation constant for binding of the unlabelled antagonist, [L] is the concentration of radioligand and K d is the equilibrium dissociation constant of the radioligand. Values are presented as mean ± SEM.
